ASCOT-LLA: Difference between revisions
Jump to navigation
Jump to search
Rim Halaby (talk | contribs) Created page with "__NOTOC__ {{LDL}} {{CMG}} '''Click here to download slides for ASCOT-LLA.''' ==Objective== ==References== {{Reflist|2}} {{Lipopedia}} Category:Lipopedia Cate..." |
Rim Halaby (talk | contribs) |
||
| (One intermediate revision by the same user not shown) | |||
| Line 5: | Line 5: | ||
'''Click [[xxx|here]] to download slides for ASCOT-LLA.''' | '''Click [[xxx|here]] to download slides for ASCOT-LLA.''' | ||
== | ==Overview== | ||
Hypertensive patients (n=10305) with total cholesterol < 251 mg/dL were randomly assigned to atorvastatin 10 mg daily and a significant reduction in non-fatal MI, fatal CHD and stoke (fatal and non-fatal) was noticed. No significant difference was observed on all-cause mortality. The trial was stopped earlier than expected of 5 years because of beneficial treatment<ref name="pmid12686036">{{cite journal| author=Sever PS, Dahlöf B, Poulter NR, Wedel H, Beevers G, Caulfield M et al.| title=Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. | journal=Lancet | year= 2003 | volume= 361 | issue= 9364 | pages= 1149-58 | pmid=12686036 | doi=10.1016/S0140-6736(03)12948-0 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12686036 }} [http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14594409 Review in: ACP J Club. 2003 Nov-Dec;139(3):57] </ref>. | |||
==References== | ==References== | ||
Latest revision as of 04:14, 29 September 2014
|
Low Density Lipoprotein Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
ASCOT-LLA On the Web |
|
American Roentgen Ray Society Images of ASCOT-LLA |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Click here to download slides for ASCOT-LLA.
Overview
Hypertensive patients (n=10305) with total cholesterol < 251 mg/dL were randomly assigned to atorvastatin 10 mg daily and a significant reduction in non-fatal MI, fatal CHD and stoke (fatal and non-fatal) was noticed. No significant difference was observed on all-cause mortality. The trial was stopped earlier than expected of 5 years because of beneficial treatment[1].
References
- ↑ Sever PS, Dahlöf B, Poulter NR, Wedel H, Beevers G, Caulfield M; et al. (2003). "Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial". Lancet. 361 (9364): 1149–58. doi:10.1016/S0140-6736(03)12948-0. PMID 12686036. Review in: ACP J Club. 2003 Nov-Dec;139(3):57